General Information |
| Board Constituency: |
Private sector |
| Is your organization legally registered in your country: |
Yes |
| If yes, please enter your registration number: |
|
| Organization Type - Primary: |
Private Sector |
| Organization Type - Secondary: |
Company |
| Organization Description: |
| The company has successfully trialled its TB Breathalyser on hundreds of patients in India and Ethiopia. The Breathalyser device for the rapid screening of active TB takes 2 minutes to display a result while the person tested waits for their result. RBS will continue to develop innovative sensor designs based on its patented immunosensor plateform. Potential business opportunities exist for Bovine TB, E.Coli snd Malaria and RBS seeks funding and collaborations in these product application sectors. |
| |
| Do you know about the UNHLM declaration: |
|
Other Organization Information |
| Total number of staff in your organization: |
1 - 5 |
| Number of full-time staff who are directly involved with TB: |
1 - 5 |
| Number of part-time staff who are directly involved with TB: |
1 - 5 |
| Number of volunteers who are directly involved with TB: |
0 |
| |
| How did you hear about the Stop TB Partnership: |
Other partners |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: |
|
| Why do you wish join the Stop TB Partnership: |
Information on developments within the TB world |
| |
| Are you a member of a Stop TB national partnership: |
United Kingdom |
| Are you in contact with your national TB programme: |
Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: |
| By developing the world's fastest and reliable test for detecting active TB. The test kit is portable, low cost and can be used by personnel who do not require medical training. By screening active TB in 2 minutes it will be possible to deliver TB test results to people while they wait. If they are TB positive they can access treatment quicker and stop spreading the active TB infection to others. |
| |
Geographical Reach |
| Which country is your headquarters located in: |
United Kingdom of Great Britain and Northern Ireland |
Which countries do you do operate in:
(This includes countries you are conducting activities in) |
Ethiopia
India
South Africa
United Kingdom of Great Britain and Northern Ireland
United States of America
|
